BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 17200429)

  • 21. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
    Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
    J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
    Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience.
    Jackson M; Callaghan S; Stapleton J; Bolton S; Austin D; Muir DF; Sutton AGC; Wright RA; Williams PD; Hall JA; Carter J; de Belder MA; Swanson N
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):359-364. PubMed ID: 30614246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel desensitization after drug-eluting stent placement.
    von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
    J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease).
    Rossini R; Iorio A; Pozzi R; Bianco M; Musumeci G; Leonardi S; Lettieri C; Bossi I; Colombo P; Rigattieri S; Dossena C; Anzuini A; Capodanno D; Senni M; Angiolillo DJ
    Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologist.
    Pattanaik D; Lieberman P; Das P
    Future Cardiol; 2012 Jul; 8(4):555-62. PubMed ID: 22871195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
    Walker NE; Fasano MB; Horwitz PA
    J Invasive Cardiol; 2006 Jul; 18(7):341-4. PubMed ID: 16816444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rapid aspirin desensitization in patients with a history of aspirin hypersensitivity requiring coronary angioplasty. Report of four cases].
    Veas P N; Martínez G; Jalil M J; Martínez S A; Castro G P
    Rev Med Chil; 2013 Feb; 141(2):255-9. PubMed ID: 23732500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases].
    Cardona R; Ramírez RH; Reina Z; Escobar MF; Morales E
    Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements.
    Pfaar O; Klimek L
    Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):161-6. PubMed ID: 16670507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to "rapid desensitization for patients with aspirin sensitivity".
    Honsinger RW
    Am J Cardiol; 2006 Jan; 97(2):294; author reply 294. PubMed ID: 16442383
    [No Abstract]   [Full Text] [Related]  

  • 33. [Safety of reintroducing platelet-inhibitory doses of aspirin in patients with urticaria or angioedema induced by anti-inflammatory doses].
    Vial A; Mathelier-Fusade P; Gaouar H; Leynadier F; Chosidow O; Aractingi S; Francès C
    Ann Dermatol Venereol; 2009 Jan; 136(1):15-20. PubMed ID: 19171224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema.
    Wong JT; Nagy CS; Krinzman SJ; Maclean JA; Bloch KJ
    J Allergy Clin Immunol; 2000 May; 105(5):997-1001. PubMed ID: 10808182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
    Nguyen MC; Lim YL; Walton A; Lefkovits J; Agnelli G; Goodman SG; Budaj A; Gulba DC; Allegrone J; Brieger D;
    Eur Heart J; 2007 Jul; 28(14):1717-22. PubMed ID: 17562671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
    Denardo SJ; Davis KE; Tcheng JE
    Am J Cardiol; 2007 Nov; 100(9):1376-82. PubMed ID: 17950793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery.
    Blasco-Colmenares E; Perl TM; Guallar E; Baumgartner WA; Conte JV; Alejo D; Pastor-Barriuso R; Sharrett AR; Faraday N
    Arch Intern Med; 2009 Apr; 169(8):788-96. PubMed ID: 19398691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Desensitization in drug hypersensitivity].
    Piotrowicz-Wójcik K; Porebski G; Czarnobilska E
    Przegl Lek; 2013; 70(12):1008-10. PubMed ID: 24720117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.